Research
June 10, 2022
Cancer Institute Retreat Highlights Novel Therapeutic Targets and Agents
The Winthrop P. Rockefeller Cancer Institute held its second annual scientific research retreat May 26 at the Marriott Hotel in Little Rock. More than 140 scientists gathered in person for the first time in two years. The retreat theme, “Molecular Targets and Cancer Therapeutics,” reflects the growth in the identification of new and novel molecular…
June 9, 2022
Arkansas Undergraduates ‘Speed Date’ with Research at UAMS Obesity and Diabetes Workshop
The University of Arkansas for Medical Sciences (UAMS) presented undergraduate students with an opportunity to learn more about obesity and diabetes at a uniquely structured workshop May 25. The workshop, hosted by Arkansas INBRE (IDeA Network of Biomedical Research Excellence), was attended by 15 students from around the state. There were presentations from seven UAMS…
June 7, 2022
UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East
LITTLE ROCK — More than 300 Arkansas veterans will become part of a new study conducted by the University of Arkansas for Medical Sciences (UAMS) and the Central Arkansas Veterans Healthcare System (CAVHS) to determine if exposure to open pit burning and molecular-level changes are associated with chronic health conditions. The Department of Veterans Affairs…
June 2, 2022
UAMS Study First to Test When Common Arsenic Exposures Are Most Likely to Cause Male Infertility in Offspring
LITTLE ROCK — In the first study of its kind, researchers at the University of Arkansas for Medical Sciences (UAMS) will test when exposure to inorganic arsenic — a common, harmful environmental toxin — is most likely to lead to infertility traits that may last for generations. The study, supported by a five-year, $2.54 million…
June 1, 2022
Study Shows That Arkansas Minorities Experienced Abnormally High Rates of COVID-19 Infection
LITTLE ROCK — Researchers from multiple Arkansas agencies conducted an eight-month study which revealed that the state’s Hispanic and Black populations had higher COVID-19 infection rates than whites. This project, which Open Forum Infectious Disease published, used seroprevalence of antibodies to COVID-19 as an indicator. Antibodies are created by a person’s immune system once they…
May 26, 2022
Four UAMS Faculty Receive 2022 Provost’s Innovator Awards
The University of Arkansas for Medical Sciences (UAMS) announced four UAMS faculty as recipients of the Provost’s Innovator Awards. The awards were established by Stephanie Gardner, Pharm.D., Ed.D., UAMS provost and chief strategy officer, and Shuk-Mei Ho, Ph.D., vice chancellor for Research and Innovation. The grants of $25,000 each support groundbreaking, innovative, high-impact projects that…
May 23, 2022
UAMS Begins Final Study of First Rapid Test for Acetaminophen Toxicity with $3.2 Million Grant
The first rapid diagnostic test for acetaminophen toxicity has cleared a major hurdle on its long road to the marketplace from UAMS.
May 20, 2022
ARresearch Study Participants Celebrated on Clinical Trials Day
As part of international Clinical Trials Day 2022, research leaders saluted the more than 8,400 Arkansas volunteers in the ARresearch registry at UAMS.
May 19, 2022
UAMS Study Found Large Segment of Arkansans Still Susceptible to COVID-19 in Late 2020, 2021
LITTLE ROCK — A team of scientists at the University of Arkansas for Medical Sciences (UAMS) carried out an eight-month seroprevalence survey that found 85% of the state’s population was still susceptible to the virus in late 2020. This project – which the Public Library of Science ONE recently published – focused on the number…
May 16, 2022
UAMS Infectious Disease Researchers Awarded $5.7 Million COBRE Grant Extension
LITTLE ROCK — The National Institute of General Medical Sciences within the National Institutes of Health awarded an additional $5.7 million, five-year grant to fund the third and final phase of a University of Arkansas for Medical Sciences program that supports infectious disease research. This final phase of the Centers for Biomedical Research Excellence (COBRE)…
Previous page Next page